Photo-Bethencourt-Ryan-02-by-Melissa-Schwartz

Featured In:

Follow:

LinkedIn

Ryan Bethencourt

CEO and Co-founder, Berkeley Biolabs
Program Director and Venture Partner, Indie.Bio

Ryan Bethencourt prides himself on disrupting the current status quo in both medical and consumer biotech. He serves as the newly appointed senior director of prize development at XPRIZE Foundation, tasked with the development of life sciences XPRIZES that drive radical breakthroughs. Ryan is also the co-founder and CEO of Berkeley Biolabs, a biohacker accelerator, and the co-founder of Sudo Room and Counter Culture Labs, where he still retains a board seat. Ryan has worked over the last decade in the biopharmaceutical industry to partner on and develop novel drugs from first IND submission to FDA approval with many major biopharmas including Pfizer, AZ, J&J, Sanofi, Takeda, Amgen, Genentech, and other companies in the U.S., E.U., and Japan. He’s also served as COO at Genescient Pharmaceuticals, a longevity focused biotech startup, and CEO of Halpin Neurosciences, an ALS focused startup. Ryan’s work has been featured in TechCrunch, Forbes, the San Francisco Business Times, and other publications. He regularly speaks on biotech innovation and writes for Biocoder, an O’Reilly Media publication.
Photo by Melissa Schwartz